Erratum: Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through akt1-mediated phosphorylation of the EphA2 receptor (Journal of Proteome Research (2011) 10 (2566-2578) DOI: 10.1021/pr200037u);Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor

Journal of Proteome Research

Volumn 10, Issue 5, 2011, Pages 2566-2578

  Ståhl, Sara ^a   Branca, Rui ^a   Efazat, Ghazal ^a   Ruzzene, Maria ^b   Zhivotovsky, Boris ^a   Lewensohn, Rolf ^a   Viktorsson, Kristina ^a   Lehtiö, Janne ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c SCIENCE FOR LIFE LABORATORY   (Sweden)

Author keywords

Akt1; EphA2; ephrin B3; lung cancer; phosphoproteomics

Indexed keywords

EPHRIN B3; EPHRIN RECEPTOR A2; HEAT SHOCK PROTEIN 90; PROTEIN KINASE B;

ARTICLE; CANCER SURVIVAL; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 79955852758     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200745f     Document Type: Erratum

References (40)

1. Herbst, R. S.; Heymach, J. V.; Lippman, S. M. Lung cancer N. Engl. J. Med. 2008, 359 (13) 1367-80
2. Hemstrom, T. H.; Joseph, B.; Schulte, G.; Lewensohn, R.; Zhivotovsky, B. PKC 412 sensitizes U1810 non-small cell lung cancer cells to DNA damage Exp. Cell Res. 2005, 305 (1) 200-13 (Pubitemid 40380666)
3. Hemstrom, T. H.; Sandstrom, M.; Zhivotovsky, B. Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells Int. J. Cancer 2006, 119 (5) 1028-38 (Pubitemid 44116909)
4. Brantley-Sieders, D.; Schmidt, S.; Parker, M.; Chen, J. Eph receptor tyrosine kinases in tumor and tumor microenvironment Curr. Pharm. Des. 2004, 10 (27) 3431-42 (Pubitemid 39276627)
5. Pasquale, E. B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond Nat. Rev. Cancer 2010, 10 (3) 165-80
6. Hsieh, C. Y.; Nakamura, P. A.; Luk, S. O.; Miko, I. J.; Henkemeyer, M.; Cramer, K. S. Ephrin-B reverse signaling is required for formation of strictly contralateral auditory brainstem pathways J. Neurosci. 2010, 30 (29) 9840-9
7. Wada, N.; Kimura, I.; Tanaka, H.; Ide, H.; Nohno, T. Glycosylphosphatidylinositol-anchored cell surface proteins regulate position-specific cell affinity in the limb bud Dev. Biol. 1998, 202 (2) 244-52 (Pubitemid 28476316)
8. McCarron, J. K.; Stringer, B. W.; Day, B. W.; Boyd, A. W. Ephrin expression and function in cancer Future Oncol. 2010, 6 (1) 165-76
9. Hafner, C.; Schmitz, G.; Meyer, S.; Bataille, F.; Hau, P.; Langmann, T. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers Clin. Chem. 2004, 50 (3) 490-9 (Pubitemid 38297297)
10. Kinch, M. S.; Moore, M. B.; Harpole, D. H., Jr. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival Clin. Cancer Res. 2003, 9 (2) 613-8 (Pubitemid 36182592)
11. Pisick, E.; Jagadeesh, S.; Salgia, R. Receptor tyrosine kinases and inhibitors in lung cancer Sc. World J. 2004, 4, 589-604
12. Brannan, J. M.; Sen, B.; Saigal, B.; Prudkin, L.; Behrens, C.; Solis, L. EphA2 in the early pathogenesis and progression of non-small cell lung cancer Cancer Prev. Res. 2009, 2 (12) 1039-49
13. Brannan, J. M.; Dong, W.; Prudkin, L.; Behrens, C.; Lotan, R.; Bekele, B. N. Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer Clin. Cancer Res. 2009, 15 (13) 4423-30
14. Ahrens, C. H.; Brunner, E.; Qeli, E.; Basler, K.; Aebersold, R. Generating and navigating proteome maps using mass spectrometry Nat. Rev. Mol. Cell. Biol. 2010, 11 (11) 789-801
15. Villen, J; Gygi, S. P. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry Nat. Protoc. 2008, 3 (10) 1630-8
16. Pinkse, M. W.; Mohammed, S; Gouw, J. W.; van Breukelen, B; Vos, H. R.; Heck, A. J. Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster J. Proteome Res. 2008, 7 (2) 687-97 (Pubitemid 351294031)
17. Lemeer, S.; Heck, A. J. The phosphoproteomics data explosion Curr. Opin. Chem. Biol. 2009, 13 (4) 414-20
18. Stahl, S.; Fung, E.; Adams, C.; Lengqvist, J.; Mork, B.; Stenerlow, B. Proteomics and pathway analysis identifies JNK signaling as critical for high linear energy transfer radiation-induced apoptosis in non-small lung cancer cells Mol. Cell. Proteomics 2009, 8 (5) 1117-29
19. Nakada, M.; Drake, K. L.; Nakada, S.; Niska, J. A.; Berens, M. E. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1 Cancer Res. 2006, 66 (17) 8492-500 (Pubitemid 44449162)
20. Di Maira, G.; Salvi, M.; Arrigoni, G.; Marin, O.; Sarno, S.; Brustolon, F. Protein kinase CK2 phosphorylates and upregulates Akt/PKB Cell Death Differ. 2005, 12 (6) 668-77 (Pubitemid 40767169)
21. Katoh, M. Comparative integromics on Eph family Int. J. Oncol. 2006, 28 (5) 1243-7
22. Genander, M.; Ephrins, F. J. and Eph receptors in stem cells and cancer Curr. Opin. Cell Biol. 2010, 22 (5) 611-6
23. Brantley-Sieders, D. M.; Fang, W. B.; Hicks, D. J.; Zhuang, G.; Shyr, Y.; Chen, J. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression FASEB J. 2005, 19 (13) 1884-6 (Pubitemid 41598783)
24. Fang, W. B.; Brantley-Sieders, D. M.; Parker, M. A.; Reith, A. D.; Chen, J. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis Oncogene 2005, 24 (53) 7859-68 (Pubitemid 41715192)
25. Liu, D. P.; Wang, Y.; Koeffler, H. P.; Xie, D. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK Int. J. Oncol. 2007, 30 (4) 865-71
26. Meyer, S.; Hafner, C.; Guba, M.; Flegel, S.; Geissler, E. K.; Becker, B. Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells Int. J. Oncol. 2005, 27 (5) 1197-206
27. Miyazaki, T.; Kato, H.; Fukuchi, M.; Nakajima, M.; Kuwano, H. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma Int. J. Cancer 2003, 103 (5) 657-63 (Pubitemid 36091471)
28. Shibue, T.; Weinberg, R. A. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (25) 10290-5
29. Assoian, R. K.; Klein, E. A. Growth control by intracellular tension and extracellular stiffness Trends Cell Biol. 2008, 18 (7) 347-52
30. Abbi, S.; Guan, J. L. Focal adhesion kinase: protein interactions and cellular functions Histol. Histopathol. 2002, 17 (4) 1163-71
31. Faoro, L; Singleton, P. A.; Cervantes, G. M.; Lennon, F. E.; Choong, N. W.; Kanteti, R. EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation J. Biol. Chem. 2010, 285 (24) 18575-85
32. Ireton, R. C.; Chen, J. EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics Curr. Cancer Drug Targets 2005, 5 (3) 149-57 (Pubitemid 40694857)
33. Miao, H.; Li, D. Q.; Mukherjee, A.; Guo, H.; Petty, A.; Cutter, J. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt Cancer Cell 2009, 16 (1) 9-20
34. Savitski, M. M.; Lemeer, S.; Boesche, M.; Lang, M.; Mathieson, T.; Bantscheff, M. Confident phosphorylation site localization using the Mascot Delta Score. Mol. Cell. Proteomics 2010, not supplied.
35. Boja, E. S.; Phillips, D.; French, S. A.; Harris, R. A.; Balaban, R. S. Quantitative mitochondrial phosphoproteomics using iTRAQ on an LTQ-Orbitrap with high energy collision dissociation J. Proteome Res. 2009, 8 (10) 4665-75
36. Zhang, Y.; Ficarro, S. B.; Li, S.; Marto, J. A. Optimized Orbitrap HCD for quantitative analysis of phosphopeptides J. Am. Soc. Mass Spectrom. 2009, 20 (8) 1425-34
37. Ruzzene, M.; Pinna, L. A. Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim. Biophys. Acta 2010, 1804 (3) 499-504
38. Salvi, M.; Sarno, S.; Cesaro, L.; Nakamura, H.; Pinna, L. A. Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis Biochim. Biophys. Acta 2009, 1793 (5) 847-59
39. Annamalai, B.; Liu, X.; Gopal, U.; Isaacs, J. S. Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis Mol. Cancer Res. 2009, 7 (7) 1021-32
40. Furne, C.; Ricard, J.; Cabrera, J. R.; Pays, L.; Bethea, J. R.; Mehlen, P. EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis Biochim. Biophys. Acta 2009, 1793 (2) 231-8